EquiSeq is conducting a study of the effect of myopathy variants (P2, P3, and P4) on Thoroughbred performance.
We seek registered Thoroughbreds of any age for this study.
To have your Thoroughbred included in the study, you must be a horse owner in the United States with one or more registered Thoroughbreds.
Your Thoroughbred must be included in the Pedigree Online Thoroughbred Database.
You must be willing to submit a 10 ml EDTA blood draw at EquiSeq’s expense. We will cover all costs, including vet fees.
If your horse is selected for the study, you will receive results for P2, P3, P4, and Px at no cost to you.
If you have a horse that meets these criteria, please email Paul Szauter at email@example.com.
Please feel free to share this message.
Free testing for registered Thoroughbreds will end on September 1, 2018. Thoroughbred owners who have initiated contact with EquiSeq prior to that time will receive free testing.